OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weekly shot could help shed pounds without diabetes
Disease control Recruiting nowThis study tests a once-weekly injection called enicepatide to help people with obesity or overweight lose weight. About 2000 adults who do not have type 2 diabetes will receive either the drug or a placebo for 72 weeks. The main goal is to see how much weight they lose and if th…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New weekly shot aims to tackle obesity and diabetes together
Disease control Recruiting nowThis study tests a new weekly injection called enicepatide in 1600 adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if it helps with weight loss compared to a placebo over 72 weeks. Participants must be on stable diabetes treatment and h…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Could a Weight-Loss drug help tame Crohn's? new trial investigates
Disease control Recruiting nowThis study tests whether adding a weight-loss drug (tirzepatide) to a standard Crohn's treatment (mirikizumab) helps people with both Crohn's disease and obesity or overweight. About 290 adults will receive either mirikizumab alone or mirikizumab plus tirzepatide for up to 61 wee…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo aims to tame gut inflammation and shed pounds together
Disease control Recruiting nowThis study tests whether adding tirzepatide (a weight-loss drug) to mirikizumab (an anti-inflammatory drug) helps people with moderate-to-severe ulcerative colitis who are also overweight or obese. About 350 adults will receive either both drugs or mirikizumab alone for up to 52 …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
New obesity drug tested for safety and drug interactions
Knowledge-focused Recruiting nowThis early-stage study tests an experimental injection called GZR18 in 60 overweight or obese adults. The goal is to see how it affects stomach emptying and whether it changes how common medications like digoxin, rosuvastatin, and warfarin work in the body. Participants will rece…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated May 26, 2026 12:12 UTC